TrialDiabetologia2004

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data.

J-L Chiasson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.